JOINT FILING AGREEMENTJoint Filing Agreement • December 30th, 2022 • MHR Fund Management LLC • Biological products, (no disgnostic substances)
Contract Type FiledDecember 30th, 2022 Company IndustryThe undersigned hereby agree that this Initial Statement on Schedule 13G with respect to the shares of Common Stock of Iovance Biotherapeutics, Inc., dated as of December 30, 2022, is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934.